Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial

Tamim Niazi, Abdenour Nabid, Talía Malagón, Steven Tisseverasinghe, Rédouane Bettahar, Rafika Dahmane, André‐Guy Martin, M. Jolicoeur, Michael Yassa, Maroie Barkati, Levon Igidbashian, Boris Bahoric, Robert Archambault, Hugo Villeneuve, Md Mohiuddin